Petřík Miloš Ph.D.
Journals
Preclinical evaluation of anti-VEGFR2 monoclonal antibody ramucirumab labelled with zirconium-89 for tumour imaging.
Journal of Labelled Compounds & Radiopharmaceuticals.
2021,
64(7),
262-270,
ISSN: 0362-4803,
PMID: 33818828,
Iodinated Choline Transport-Targeted Tracers.
Journal of Medicinal Chemistry.
2020,
63(24),
15960–15978,
ISSN: 0022-2623,
PMID: 33271015,
Open positions
Project: | Preclinical development of molecular imaging agents |
---|---|
Supervisors: | Petřík Miloš Ph.D. |
Available: | 2 |
Intended for: | Doctoral training |
Project: | Preclinical development of substances for molecular imaging |
---|---|
Supervisors: | Petřík Miloš Ph.D. |
Available: | 1 |
Intended for: | Doctoral training |
Summary: | 1 place in full-time study |
Project: | In vivo imaging of 68Ga labelled biomolecules |
---|---|
Supervisors: | Petřík Miloš Ph.D. |
Available: | 1 |
Intended for: | Bachelor training |
Project: | Radiolabelled siderophores for infection imaging |
---|---|
Supervisors: | Petřík Miloš Ph.D. |
Available: | 1 |
Intended for: | Master training |
Project: | Radiolabelled peptides for cancer imaging |
---|---|
Supervisors: | Petřík Miloš Ph.D. |
Available: | 1 |
Intended for: | Master training |